CRYO Cryo-Save

 

TIDMCRYO 
 
 
Cryo-Save Group NV 
04 June 2010 
 
? 
4 June 2010 
 
Cryo-Save Group N.V. 
 
Scientists give the go-ahead for private storage of stem cells from umbilical 
cord blood 
 
Four world-renowned stem cell experts* have recently given their full support to 
private cordblood banking.  The four scientists supported the foundation of the 
"Family Cord Blood Bank" which has just been established in the US by CORD:USE. 
 
Cryo-Save (Euronext/AIM: CRYO), the largest stem cell bank in Europe, is very 
pleased with this positive development. 
 
Arnoud van Tulder, Cryosave CEO said 
 
"We expect that the merit of private storage of stem cells will also increase in 
Europe and that the sometimes unreasonable arguments, which prevent people from 
storing stem cells in a number of countries, will disappear.  Combined storage 
seems to be the way of the future". 
 
What is the merit of umbilical cord blood? 
Umbilical cord blood contains very valuable cells; stem cells which can multiply 
and grow into cells which can cure serious and sometimes deadly diseases. They 
are used to combat more than 70 different diseases and research into new 
applications is continuously increasing; at present, more than 3,000 clinical 
studies are in progress**. The blood and the stem cells are analyzed and 
processed using advanced technology and subsequently stored in the gas phase of 
liquid nitrogen. When needed, the cells can be used immediately. 
 
Private versus public storage? 
As a parent, you can have the umbilical cord blood with the stem cells of your 
child stored in the private or family blood bank. The stem cells are then 
available for later use and guarantee an exact match for the child concerned, 
and 25% chance that they are also an exact match for a brother or sister. 
Worldwide, hundreds of thousands of parents already decided to store the stem 
cells from the umbilical cord blood of their children in a private bank. 
 
When the choice is public storage, the parents decide to make the stem cells 
available to others. The cells can then be utilized to save the life of another, 
unknown person, who shows a match with the donor blood. However, the donor 
parents do not have any guarantee that the stem cells remain available for their 
own child as well. In addition, it turns out that only 30 to 50% of all 
donations are indeed stored. The rest is destroyed. You will only get the 
guarantee that the stem cells are available if your child needs them by storing 
in a private or family bank. 
 
Cryo-Save goes for combined storage 
With more than 130,000 samples stored and activities in more than 38 countries, 
Cryo-Save is the largest stem cell bank in Europe. 
 
The stem cells are taken from the umbilical cord and umbilical tissue. In Italy, 
Cryo-Save offers combined storage for both private as well as public use. This 
offers the guarantee that the blood is available for one's own child if it is 
ever needed, but is also available to help others. Pending approval of the 
authorities, Cryo-Save plans to introduce this "best-of-both worlds" 
combined-storage service in other countries as well. 
 
Cryo-Save (www.cryo-save.com) 
With more than 130,000 samples stored, Cryo-Save Group, with their head office 
in Zutphen, is the largest stem cell bank for stem cells from umbilical cord 
blood and umbilical cords in Europe and one of the fastest-growing in the world. 
Cryo-Save not only stores stem cells from the blood of the umbilical cord but 
distinguishes itself from its competitors in Europe, the United States and Asia 
by also storing a part of the umbilical cord itself which contains valuable 
mesenchymal stem cells (MSCs). Since May 21 of this year, Cryo-Save also stores 
MSCs from the fat tissue of adults (Cryo-Lip , http://www.cryo-lip.com). 
 
Driven by an international strategy, Cryo-Save is currently located in 38 
countries on three continents. The enterprise has highly advanced technological 
laboratories and storage facilities in Belgium, Germany, Dubai, India and France 
(in construction). 
 
Note to editors 
 
** www.clinicaltrials.gov/ct2/results?term=stem+cell 
 
* The scientific experts behind the public blood banks now also support the 
merit of private storage. Prof. Dr. Hal Broxmeyer, Prof. Dr. John Wagner, Prof. 
Dr. Joanna Kurtzberg and Prof. Dr. Elianne Gluckman are the main references 
worldwide as far as stem cell transplantations from umbilical cord blood are 
concerned. During the past 20 years, these stem cell experts have performed 
thousands of transplantations with stem cells from umbilical cord blood and have 
hundreds of publications to their credit. (More info at http://www.corduse.com). 
 
Prof. Hal Broxmeyer 
Professor Hal Broxmeyer is the founder of the public bank, CORD:USE Stem Cell 
Blood Bank, (Florida, USA)and president of the "American Society of Hematology" 
(16,000 members in 97 countries). He is internationally recognized as the 
founder of the field of stem cell transplantation using cells from umbilical 
cord blood. He was involved with the planning and coordination of the first 
successfully performed transplantation in 1988. 
 
Prof. John Wagner 
Professor John Wagner is the director of the "Stem Cell Institute of the 
University of Minnesota". He and his team were the first to use stem cells from 
the umbilical cord for the treatment of leukemia. 
 
Prof. Joanna Kurtzberg 
Professor Joanna Kurzberg is the director of "Duke University's Pediatric and 
Marrow Transplant Program" and performed the first ever successful 
transplantation with allogenous stem cells from umbilical cord blood in 1993. 
 
Prof. Elianne Gluckman 
Professor Elianne Gluckman is connected to the "Hematology University Paris VII" 
and president of the European School of Hematology. In 1988, she performed the 
first ever stem cell transplantation. 
 
http://www.corduse.com/public-cord-blood-bank/press_room/index.php?page=news&id 
25&act=view 
 
 
For more information: Cryo-Save Group +31(0)575-548-998, Arnoud van Tulder, CEO, 
Marc Waeterschoot, Executive Director 
 
For more information about this press release, surf to 
http://www.cryo-savegroup.com/investor_news.html and 
http://www.cryo-savegroup.com/company_news.html 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NRABRGDLIGGBGGX 
 

Cryo-Save (LSE:CRYO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Cryo-Save (LSE:CRYO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024